Concarlo Therapeutics
Founded in July 2016 and headquartered in Brooklyn, New York, Concarlo is a precision-medicine oncology company focused on diagnosing and treating cancer with an innovative approach to targeting a unique cellular pathway - p27Kip1. Concarlo's novel IpY therapeutic will be the first inhibitor to solve the CDK2 resistance issue, the first therapeutic to target p27 and the first to inhibit CDK4 and CDK2 simulataneously.
7-day free trial · no credit card
Verified contacts
8
available on Kipplo
LinkedIn employees
11
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 8 verified contacts at Concarlo Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
8 contacts with verified email or phone · masked until revealed.
- SB
Stacy Blain
Co-founder, Chief Scientific Officer, and Acting CEO · Other
EmailPhone - GC
Grace Chen
Director of Research · Research & Development
EmailPhone - GC
Grace Chen
Director of Research · Research & Development
EmailPhone - CG
Carolina Guido
- - · Other
EmailPhone - JC
Jay Campbell
() · Other
EmailPhone
Showing 5 of 8 verified contacts
Top roles at Concarlo Therapeutics
5 distinct titles indexed · top 5 shown.
- 2director of research
- 1()
- 1- -
- 1co-founder, chief scientific officer, and acting ceo
- 1executive assistant
Sign up to unlock all 8 contacts at Concarlo Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 8 verified contacts at Concarlo Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.